MassBio's First CRO/CMO Symposium on "Accelerating Drug Development" Met With Huge Success
14 mars 2012 11h28 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Mar 14, 2012) - The inaugural Massachusetts Biotechnology Council (MassBio) CRM/CMO Symposium was a resounding success, according to Ed Price, President of PCI...
PCI Sponsors MassBio's Massachusetts CRO/CMO Symposium
15 févr. 2012 14h16 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Feb 15, 2012) - PCI (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...
PCI Synthesis Adds Manufacturing, QC, Business, and R&D Expertise
31 janv. 2012 10h17 HE | PCI Synthesis
NEWBURYPORT, MA and NEW ORLEANS, LA--(Marketwire - Jan 31, 2012) - Informex, Booth 425 -- PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical...
PCI Synthesis Completes R&D Expansion
13 déc. 2011 12h44 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Dec 13, 2011) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
PCI Synthesis Announces 8th Successful FDA Inspection
15 nov. 2011 10h33 HE | PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Nov 15, 2011) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...